Known targets — ChEMBL curated mechanism
GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHMGCRMMP1MMP13MMP7MMP8PTGS1PTGS2ileSpolrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 1/20 | 0.50 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.45 |
| ▸ | G6PD | P11413 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.44 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1730358 | 0.96 | ERN1 (0.50) | ERN1PTPN22POLBHKDC1G6PD | |
| SCHEMBL2761906 | 0.96 | ERN1 (0.50) | ERN1PTPN22POLBHKDC1G6PD | |
| SCHEMBL29625740 | 0.82 | ERN1 (0.55) | ERN1PTPN22POLBHKDC1G6PD | |
| SCHEMBL11046405 | 0.82 | ERN1 (0.55) | ERN1PTPN22POLBHKDC1G6PD | |
| SCHEMBL564094 | 0.81 | ERN1 (0.53) | ERN1PTPN22POLBHKDC1G6PD | |
| SCHEMBL3035364 | 0.81 | ERN1 (0.53) | ERN1PTPN22POLBHKDC1G6PD | |
| SCHEMBL7203177 | 0.79 | ERN1 (0.52) | ERN1PTPN22POLBHKDC1G6PD | |
| SCHEMBL20885914 | 0.79 | ERN1 (0.52) | ERN1PTPN22POLBHKDC1G6PD | |
| SCHEMBL1730362 | 0.79 | ERN1 (0.52) | ERN1PTPN22POLBHKDC1G6PD | |
| SCHEMBL11104505 | 0.79 | CA1 (0.41) | ERN1HSD17B10HCRTR1ALDH1A1HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1005651-A1 | METHODS OF IDENTIFYING BIOLOGICAL AGENT COMPOSITIONS | SUPRATEK PHARMA, INC. (CA) | 2000-06-07 | — | — | EP | claimed |
| WO-1999008112-A1 | METHODS OF IDENTIFYING BIOLOGICAL AGENT COMPOSITIONS | SUPRATEK PHARMA INC. (CA) | 1999-02-18 | — | — | WO | claimed |
| US-20190054186-A1 | Magnetic Nanoparticle-Polymer Complexes and uses Thereof | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2019-02-21 | — | — | US | disclosed |
| WO-2017173205-A1 | MAGNETIC NANOPARTICLE-POLYMER COMPLEXES AND USES THEREOF | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2017-10-05 | — | — | WO | disclosed |
| US-8415400-B2 | Synthesizing an amphiphilic block polymer micelle having ionically-charged polymeric segments and nonionically-charged polymeric segments; neutralizing under conditions that allow for self-assembly of polymer micelles; crosslinking; removing the moieties of opposite charge; drug delivery; stability | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) | 2013-04-09 | — | — | US | disclosed |
| US-20100016392-A1 | Pesticidal Aggregates | INNOVAFORM TECHNOLOGIES, LLC (US) | 2010-01-21 | — | — | US | disclosed |
| EP-2091323-A2 | PESTICIDAL AGGREGATES | Innovaform Technologies, LLC (US) | 2009-08-26 | — | — | EP | disclosed |
| US-20080319375-A1 | Materials, Methods, and Systems for Cavitation-mediated Ultrasonic Drug Delivery in vivo | BIOVALUATION & ANALYSIS, INC. | 2008-12-25 | — | — | US | disclosed |
| WO-2008157422-A1 | MATERIALS, METHODS, AND SYSTEMS FOR CAVITATION-MEDIATED ULTRASONIC DRUG DELIVERY | HARDY CHARLES THOMAS (US) | 2008-12-24 | — | — | WO | disclosed |
| US-20080299177-A1 | Supramolecular Complexes for Use in Acoustically Mediated Intracellular Drug Delivery in vivo | BIOVALUATION & ANALYSIS, INC. | 2008-12-04 | — | — | US | disclosed |
| WO-2008076807-A2 | PESTICIDAL AGGREGATES | INNOVAFORM TECHNOLOGIES, LLC (US) | 2008-06-26 | — | — | WO | disclosed |
| EP-1109539-A1 | NANOGEL NETWORKS AND BIOLOGICAL AGENT COMPOSITION THEREOF | SUPRATEK PHARMA, INC. (CA) | 2001-06-27 | — | — | EP | disclosed |
| EP-1005324-A4 | COMPOSITIONS FOR DELIVERY OF BIOLOGICAL AGENTS AND METHODS FOR THE PREPARATION THEREOF | UNIV NEBRASKA (US) | 2001-06-06 | — | — | EP | disclosed |
| EP-1056469-A1 | NOVEL PEPTIDE COPOLYMER COMPOSITIONS | SUPRATEK PHARMA, INC. (CA) | 2000-12-06 | — | — | EP | disclosed |
| US-6093391-A | PEPTIDE COMPOSITIONS CONTAINING POLYOXYETHYLENE-POLYOXYPROPYLENE BLOCK COPOLYMERS THAT ARE USEFUL IN TREATMENT OF DISEASES AND DISORDERS WITH REDUCED SIDE EFFECTS, EASE IN ADMINISTERING TO DESIRED TARGET SITE, | SUPRATEK PHARMA, INC. (CA) | 2000-07-25 | — | — | US | disclosed |
| EP-1005324-A1 | COMPOSITIONS FOR DELIVERY OF BIOLOGICAL AGENTS AND METHODS FOR THE PREPARATION THEREOF | UNIVERSITY OF NEBRASKA BOARD OF REGENTS (US) | 2000-06-07 | — | — | EP | disclosed |
| WO-2000013677-A1 | NANOGEL NETWORKS AND BIOLOGICAL AGENT COMPOSITION THEREOF | SUPRATEK PHARMA, INC. (CA) | 2000-03-16 | — | — | WO | disclosed |
| WO-1999043343-A1 | NOVEL PEPTIDE COPOLYMER COMPOSITIONS | SUPRATEK PHARMA INC. (CA) | 1999-09-02 | — | — | WO | disclosed |
| WO-1998056334-A1 | COMPOSITIONS FOR DELIVERY OF BIOLOGICAL AGENTS AND METHODS FOR THE PREPARATION THEREOF | UNIVERSITY OF NEBRASKA BOARD OF REGENTS (US) | 1998-12-17 | — | — | WO | disclosed |
| WO-1998056348-A1 | COMPOSITIONS FOR DELIVERY OF BIOLOGICAL AGENTS AND METHODS FOR THE PREPARATION THEREOF | UNIVERSITY OF NEBRASKA BOARD OF REGENTS (US) | 1998-12-17 | — | — | WO | disclosed |